Similar articles

• NSAIDs double risk of bleeding in patients taking antithrombotics after myocardial infarction, study finds.

  Mayor S. Mayor S. BMJ. 2015 Feb 24;350:h1043. doi: 10.1136/bmj.h1043. BMJ. 2015. PMID: 25716233 No abstract available.
• Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.

  Schjerning Olsen AM, Gislason GH, McGettigan P, Fosbøl E, Sørensen R, Hansen ML, Køber L, Torp-Pedersen C, Lamberts M. Schjerning Olsen AM, et al. JAMA. 2015 Feb 24;313(8):805-14. doi: 10.1001/jama.2015.0809. JAMA. 2015. PMID: 25710657
• Acute coronary syndromes. Risks linked to NSAID use after MI.

  Mearns BM. Mearns BM. Nat Rev Cardiol. 2015 May;12(5):257. doi: 10.1038/nrcardio.2015.36. Epub 2015 Mar 17. Nat Rev Cardiol. 2015. PMID: 25781414 No abstract available.
• Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.

  Schmidt M, Lamberts M, Olsen AM, Fosbøll E, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C. Schmidt M, et al. Eur Heart J. 2016 Apr 1;37(13):1015-23. doi: 10.1093/eurheartj/ehv505. Epub 2016 Mar 16. Eur Heart J. 2016. PMID: 26984863 Review. No abstract available.
• Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease.

  Ross SJ, Elgendy IY, Bavry AA. Ross SJ, et al. Curr Cardiol Rep. 2017 Jan;19(1):8. doi: 10.1007/s11886-017-0814-5. Curr Cardiol Rep. 2017. PMID: 28138824 Review.